Home » Topics » BioWorld Science

BioWorld Science
RSS

ADAM-17 inhibitor ZLDI-8 increases cancer sensitivity to chemotherapeutic drugs

Aug. 17, 2018

HitGen to collaborate with LG Chem on drug discovery using DNA-encoded libraries

Aug. 17, 2018

Lenvatinib approved in the U.S. for unresectable hepatocellular carcinoma

Aug. 17, 2018

TrovaGene completes second dosing cohort in phase Ib/II study of onvansertib in AML

Aug. 17, 2018

Fasinumab topline phase III data presented in patients with chronic pain from OA of the knee or hip

Aug. 17, 2018

Principia Biopharma patents proteasome subunit beta type-8/beta type-9 inhibitors

Aug. 17, 2018

Sihuan Pharmaceutical begins phase II study of pirotinib

Aug. 17, 2018

Development of novel broad coverage human papilloma virus vaccines

Aug. 17, 2018

Metabolism targeting compound kills brain tumor cells

Aug. 17, 2018

Release of phase IIa clinical data concerning a first-in-class drug for type 2 diabetes treatment

Aug. 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...